Algernon Pharmaceuticals Inc (AGNPF)

[Money $hot]

@ the 12:30 min/sec mark the CEO completely dodges the actual question being asked by the interviewer with an offhand analogy. The true meaning of the question is why the hell did management wait so FN long before they went after CKD along with the existing drugs already purchased in the reverse takeover of Breathtec Biomedical? Moreau went off on a long and drawn out tangent to the point you damn couldn't remember the original question. Moreau has no good answer for why they sat on CKD. Just like he has no reasonable answer for why they rolled Chronic Cough into the IPF study in Australia. One can tell Moreau is still chomping at the bit to get back to slow bus studies in Australia versus getting to actual data readouts expeditiously. Managements incompetence shtick is way past old now and none of us are getting any younger.

M$